Octo Consulting to Provide Data Analytics to FDA

February 8, 2018

The U.S. Food and Drug Administration (FDA) awarded a $300 million blanket purchase agreement to Reston, Virginia-based Octo Consulting Group.* Under the contract, Octo will support the development of the FDA's Drug Resource Management System. According to the company, Octo will provide advanced data analytics to help improve the FDA Center for Drug Evaluation and Research's (CDER's) regulatory, surveillance, compliance, enforcement and oversight capabilities, as well as meeting the requirements of the 21st Century Cure Act. *Small business.

Enjoyed this article? SUBSCRIBE NOW to keep the content flowing.